Litcius/Paper detail

Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients

Suiting Ao, Xuemei Gao, Jipang Zhan, A. Lu, Minyi Li, Huilin Su, Xuhua Tang, Coco Chu, Jiande Han, Fang Wang

2022Journal of the American Academy of Dermatology39 citationsDOI

Topics & Concepts

MedicineToxic epidermal necrolysisEtanerceptMethylprednisoloneTumor necrosis factor alphaInternal medicineMinocyclineGastroenterologyImmunologyDermatologyAntibioticsMicrobiologyBiologyDrug-Induced Adverse ReactionsContact Dermatitis and AllergiesBlood disorders and treatments
Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients | Litcius